This inventor holds 1 USPTO granted patent and 7 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignee: Reneuron, Inc.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Lara Stevanato: Innovator in Stem Cell Research
Introduction
Lara Stevanato is a prominent inventor based in Guildford, GB. She has made significant contributions to the field of stem cell research, particularly in the development of innovative therapies for cancer treatment. Her work focuses on the use of stem cell microparticles and miRNA, showcasing her dedication to advancing medical science.
Latest Patents
Lara holds a patent for her invention titled "Stem cell microparticles and miRNA." This invention relates to stem cell microparticles and miRNA isolated from these microparticles, emphasizing their production and therapeutic applications. Specifically, her research targets neural stem cell microparticles and their potential use in treating various cancers, including glioma, melanoma, breast cancer, pancreatic cancer, and prostate cancer. The stem cell microparticle is typically an exosome or microvesicle derived from a neural stem cell line, such as the conditionally-immortalized CTX0E03.
Career Highlights
Lara is currently associated with Reneuron, Inc., where she continues to push the boundaries of stem cell research. Her innovative approach and commitment to her work have positioned her as a key figure in the field.
Collaborations
Lara collaborates with esteemed colleagues, including Caroline Hicks and John Sinden, who share her passion for advancing stem cell therapies. Their combined expertise fosters a dynamic research environment that enhances the potential for groundbreaking discoveries.
Conclusion
Lara Stevanato's contributions to stem cell research and her innovative patent demonstrate her commitment to improving cancer therapies. Her work not only highlights the potential of stem cell microparticles but also paves the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile